Showing 221-230 of 3001 results for "".
Proposed Hospital Standards for Parkinson Disease Care Aim to Avoid Preventable Harm
https://practicalneurology.com/programs/practical-neurology/proposed-hospital-standards-for-parkinson-disease-care-aim-to-avoid-preventable-harm/35438/Preventable harm is a serious concern for patients with Parkinson disease who receive care in the hospital setting, even when admitted for reasons other than their diagnosis. Peter Pronovost, MD, PhD, FCCM, Chief Quality and Transformation Officer at University Hospitals Cleveland Medical Center, ClRedefining Life with Friedreich Ataxia
https://practicalneurology.com/diseases-diagnoses/neuromuscular/redefining-life-with-friedreich-ataxia/30099/We speak with neuromuscular disease expert David Lynch, MD, PhD, attending neurologist in the Division of Neurology at Children's Hospital of Philadelphia and director of the Friedreich Ataxia Program, about the emerging treatment landscape for Friedreich ataxia as well as Kiersten Riggs, who discusNMOSD Part 1 - Overview and important considerations for diagnosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/nmosd-part-1-overview-and-important-considerations-for-diagnosis/30086/In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podThe Consequences of Delays in the Diagnosis of Generalized Myasthenia Gravis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/the-consequences-of-delays-in-the-diagnosis-of-generalized-myasthenia-gravis/39223/Delayed diagnosis of generalized myasthenia gravis is a common challenge, often leading to misdiagnosis, increased disease severity, and reduced quality of life. In this episode of NeuroFrontiers, John A. Morren, MD, FAAN, FAANEM discusses why diagnostic delays occur, how they impact patient outcomeNavigating Treatment Decisions for Individuals with Spinal Muscular Atrophy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/navigating-treatment-decisions-for-individuals-with-spinal-muscular-atrophy/39222/Spinal muscular atrophy (SMA) care has shifted dramatically with the introduction of disease-modifying therapies, but how do clinicians weigh treatment options across different patient populations? In this episode of NeuroFrontiers, Charles Turck, PharmD, BCPS, BCCP, speaks with John Brandsema, MD aUpdates from the American Headache Society: Diagnostic Criteria, Preventive CGRP Therapy, and Treatment Guidance
https://practicalneurology.com/diseases-diagnoses/headache-pain/updates-from-the-american-headache-society-diagnostic-criteria-preventive-cgrp-therapy-and-treatment-guidance/37873/Jessica Ailani, MD, FAHS, FAAN, FANA, Clinical Professor of Neurology at MedStar’s Georgetown University Hospital and Director of the MedStar Georgetown Headache Center, joins Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, to review essential American Headache Society updates for migrPractice Management: New Solutions for Old Problems
https://practicalneurology.com/diseases-diagnoses/neuromuscular/1109_03-php/30872/Big changes to Medicare are coming. Here's a look at how you and your practice can prepare for success in the new decade.Insider Tips on Disability Applications and Another Take on the MSE
https://practicalneurology.com/columns/practice-management/PN0609_08-php/30912/Parkinson's Pipeline: Promise in Research and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/parkinsons-pipeline-promise-in-research-and-treatment/30506/At the Michael J. Fox Foundation's Parkinson's Disease Therapeutics Conference, experts revealed encouraging new directions in treating and understanding PD.When Migraine Treatments Fails: Navigating Therapy Switching
https://practicalneurology.com/diseases-diagnoses/headache-pain/when-migraine-treatments-fails-navigating-transitions-in-therapy/37870/What happens when first-line migraine therapies don’t deliver? Vincent Martin, MD, FACP, FAHS, Director of the Headache and Facial Pain Center at the Gardner Neuroscience Institute and Professor of Clinical Medicine in the Division of Internal Medicine at the University of Cincinnati, OH, joins Char